Gossamer Bio, Inc. (GOSS)
NASDAQ: GOSS · Real-Time Price · USD
0.886
+0.013 (1.44%)
At close: Nov 4, 2024, 4:00 PM
0.876
-0.011 (-1.21%)
Pre-market: Nov 5, 2024, 9:04 AM EST
Gossamer Bio Employees
Gossamer Bio had 135 employees as of December 31, 2023. The number of employees decreased by 43 or -24.16% compared to the previous year.
Employees
135
Change (1Y)
-43
Growth (1Y)
-24.16%
Revenue / Employee
$709,941
Profits / Employee
-$598,904
Market Cap
200.51M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Biodesix | 217 |
Electromed | 174 |
ProKidney | 163 |
Caribou Biosciences | 158 |
Senseonics Holdings | 132 |
MediWound | 100 |
Fulcrum Therapeutics | 76 |
Orchestra BioMed Holdings | 56 |
GOSS News
- 4 weeks ago - Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 2 months ago - Gossamer Bio Has One More Shot On Goal And Is Not Likely To Miss - Seeking Alpha
- 2 months ago - Gossamer Bio Announces Data Presentations at the European Respiratory Society Congress 2024 - Business Wire
- 2 months ago - Presenting on the Emerging Growth Conference 74 Day 1 on August 21 Register Now - GlobeNewsWire
- 3 months ago - Gossamer Bio Announces Second Quarter 2024 Financial Results and Provides Business Update - Business Wire
- 4 months ago - Gossamer Bio's Clean Safety Profile Differentiates It From Merck, Analyst Says - Benzinga
- 6 months ago - Gossamer Bio to Provide Updated Seralutinib TORREY Open-Label Extension Data at the American Thoracic Society 2024 International Conference - Business Wire
- 6 months ago - Gossamer Bio Announces First Quarter 2024 Financial Results and Provides Business Update - Business Wire